UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)
MICROMET, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE, $0.00004 PER SHARE
(Title of Class of Securities)
13738Y107
(CUSIP Number)
Kristin Bailey
c/o Forward Ventures
9393 Towne Centre Drive
Suite 200
San Diego, CA 92121
Tel 858.677.6077
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
May 5, 2006
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act.
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Forward Ventures IV, L.P.
I.R.S. Identification No. 33-0910769
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 495,511 shares
REPORTING
PERSON ------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
0 shares
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
495,511 shares
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
495,511 shares
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
1.6%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Forward Ventures IV B, L.P.
I.R.S. Identification No. 33-0910769
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES -------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 495,511 shares
REPORTING
PERSON
WITH
-------------------------------------------------
9 SOLE DISPOSITIVE POWER
0 shares
-------------------------------------------------
10 SHARED DISPOSITIVE POWER
495,511 shares
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
495,511 shares
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
1.6%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Forward IV Associates, LLC
I.R.S. Identification No. 33-0910769
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
AF
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 0 shares
SHARES ------------------------------------------------------
BENEFICIALLY
OWNED BY
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 495,511 shares
WITH
------------------------------------------------------
9 SOLE DISPOSITIVE POWER
0 shares
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
495,511 shares
------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
495,511 shares
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
1.6%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Standish M. Fleming
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
AF
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 495,511 shares
REPORTING
PERSON ------------------------------------------------------
9 SOLE DISPOSITIVE POWER
WITH 0 shares
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
495,511 shares
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
495,511 shares
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS) [ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
1.6%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Ivor Royston, M.D.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
AF
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
3,333 shares
NUMBER OF
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 498,543 shares
REPORTING
PERSON ------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
3,333 shares
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
498,543 shares
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
501,876 shares
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
1.6%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
--------------------------------------------------------------------------------
ITEM 1. SECURITY AND ISSUER
This Amendment No. 1 amends the statement on Schedule 13D filed with the
Securities and Exchange Commission on February 10, 2004 with respect to
CancerVax Corporation ("CancerVax"), and relates to shares of common stock,
$0.00004 par value per share (the "Common Stock"), of Micromet, Inc. (the
"Company"). The address of the principal executive offices of the Company is
2110 Rutherford Road Carlsbad, CA 92008.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5 is hereby amended as follows:
As of February 12, 2007, Forward Ventures IV, L.P. ("IV, L.P.") is the
beneficial and record owner of 456,743 shares of Common Stock of the Company,
and Forward Ventures IV B, L.P. ("IV B, L.P.") is the beneficial and record
owner of 38,769 shares of Common Stock of the Company (such 495,511 shares of
Common Stock to be referred to collectively as the "Record Shares"). By virtue
of their relationship as affiliated entities with overlapping general partners,
IV, L.P. and IV B, L.P. may each be deemed to beneficially own all of the Record
Shares. By virtue of the affiliate relationship among IV, L.P., IV B, L.P. and
Forward IV Associates, LLC ("Associates LLC"), Associates LLC may be deemed to
beneficially own all of the Record Shares. In their capacities as individual
managing members of Associates LLC, each of Standish Fleming and Ivor Royston,
M.D. may be deemed to beneficially own all of the Record Shares. Ivor Royston,
M.D. is the beneficial and record owner of options to purchase 3,333 shares of
Common Stock, all of which are vested. Colette Royston, the wife of Ivor
Royston, M.D., is the beneficial and record owner of 3,032 shares of Common
Stock of the Company. Ivor Royston, M.D. shares with his wife the power to vote
or to direct the vote and the power to dispose or to direct the disposition of
these shares, and may be deemed to beneficially own the shares of Common Stock
of the Company owned beneficially by Colette Royston.
Each of the Reporting Persons expressly disclaims beneficial ownership, except
to the extent of its pecuniary interest therein, if any, of any shares of Common
Stock of the Company except in the case of IV, L.P. for the 456,742 shares of
Common Stock it holds of record, in the case of IV B, L.P. for the 38,769 shares
of Common Stock it holds of record and in the case of Ivor Royston, M.D. for the
options to purchase 3,333 shares of Common Stock he holds of record.
(a) Percent of Class: Each Reporting Person 1.6%. The foregoing
percentage is calculated based upon the 31,413,032 shares of Common
Stock reported to be outstanding in the Quarterly Report on Form
10-Q of the Company for the quarter ended September 30, 2006.
(b) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
0 shares for each Reporting Person except for Ivor Royston,
M.D.: 3,333 shares for Ivor Royston, M.D.
(ii) shared power to vote or to direct the vote:
495,511 shares for each Reporting Person other than Ivor
Royston, M.D.: 498,543 shares for Ivor Royston, M.D.
(iii) sole power to dispose or direct the disposition of:
0 shares for each Reporting Person except for Ivor Royston,
M.D.: 3,333 shares for Ivor Royston, M.D.
(iv) shared power to dispose or direct the disposition of:
495,511 shares for each Reporting Person other than Ivor
Royston, M.D.: 498,543 shares for Ivor Royston, M.D.
(c) None of the Reporting Persons has effected any transaction in the
Common Stock of the Company in during the past sixty days.
(d) No other person is known to have the right to receive or the power to
direct the receipt of dividends from, or any proceeds from the sale of the
shares beneficially owned by any of the Reporting Persons, other than Colette
Royston who has the right to receive and the power to direct the receipt of
dividends from, or any proceeds from the sale of the 3,032 shares of Common
Stock she owns.
(e) On May 5, 2006, CancerVax completed a merger with Micromet AG, a
privately-held German company. In connection with the merger, CancerVax issued
to Micromet AG stockholders an aggregate of 19,761,688 shares of CancerVax
common stock, such that as of the closing former CancerVax stockholders owned
approximately 32.5% of the combined company on a fully-diluted basis. CancerVax
was subsequently renamed "Micromet, Inc." Also on May 5, 2006 in connection with
the merger, CancerVax effected a 1-for-3 reverse stock split of its common stock
As a result of the issuance of shares of CancerVax common stock to
Micromet AG stockholders and the 1-for-3 reverse stock split, the beneficial
ownership of the Reporting Persons of outstanding shares of Common Stock of the
Company has fallen below 5% and therefore none of the Reporting Persons have any
further filing obligations with respect to the Common Stock of the Company.
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief,
each of the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Date: February 13, 2007
FORWARD VENTURES IV, L.P.
By: Forward IV Associates, LLC
By: /s/ Standish M. Fleming
-------------------------------------
Standish M. Fleming
Managing Member
FORWARD VENTURES IV B, L.P.
By: Forward IV Associates, LLC
By: /s/ Standish M. Fleming
-------------------------------------
Standish M. Fleming
Managing Member
FORWARD IV ASSOCIATES LLC
By: /s/ Standish M. Fleming
-------------------------------------
Standish M. Fleming
Managing Member
/s/ Standish M. Fleming
-------------------------------------
Standish M. Fleming
/s/ Ivor Royston, M.D.
-------------------------------------
Ivor Royston, M.D.
Exhibit 1
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as
amended, the undersigned hereby agree that only one statement containing the
information required by Schedule 13D need be filed with respect to the ownership
by each of the undersigned of shares of common stock of Micromet, Inc.
Date: February 13, 2007
FORWARD VENTURES IV, L.P.
By: Forward IV Associates, LLC
By: /s/ Standish M. Fleming
-------------------------------------
Standish M. Fleming
Managing Member
FORWARD VENTURES IV B, L.P.
By: Forward IV Associates, LLC
By: /s/ Standish M. Fleming
-------------------------------------
Standish M. Fleming
Managing Member
FORWARD IV ASSOCIATES LLC
By: /s/ Standish M. Fleming
-------------------------------------
Standish M. Fleming
Managing Member
/s/ Standish M. Fleming
-------------------------------------
Standish M. Fleming
/s/ Ivor Royston, M.D.
-------------------------------------
Ivor Royston, M.D.